110 related articles for article (PubMed ID: 7302925)
1. High pressure liquid chromatography of fibrinopeptides derived from eight mammalian fibrinogens.
Sellers JP; Clark HG
Thromb Res; 1981 Jul 1-15; 23(1-2):91-5. PubMed ID: 7302925
[No Abstract] [Full Text] [Related]
2. Fibrinopeptide A release is necessary for effective B:b interactions in polymerisation of variant fibrinogens with impaired A:a interactions.
Soya K; Terasawa F; Okumura N
Thromb Haemost; 2013 Feb; 109(2):221-8. PubMed ID: 23238100
[TBL] [Abstract][Full Text] [Related]
3. Fibrinogen Aarhus--a new case of dysfibrinogenemia.
Hessel B; Stenbjerg S; Dyr J; Kudryk B; Therkildsen L; Blombäck B
Thromb Res; 1986 Apr; 42(1):21-37. PubMed ID: 2939591
[TBL] [Abstract][Full Text] [Related]
4. Analysis of human fibrinopeptides by high-performance liquid chromatography.
Kehl M; Lottspeich F; Henschen A
Hoppe Seylers Z Physiol Chem; 1981 Dec; 362(12):1661-4. PubMed ID: 7319478
[TBL] [Abstract][Full Text] [Related]
5. Biosynthesis of canine fibrinogen: in vitro synthesis of A alpha, B beta and gamma precursor chains.
Yu S; Redman CM; Goldstein J; Blombäck B
Biochem Biophys Res Commun; 1980 Oct; 96(3):1032-8. PubMed ID: 7437057
[No Abstract] [Full Text] [Related]
6. Amino acid sequences of lamprey fibrinopeptides A and B and characterizations of the junctions split by lamprey and mammalian thrombins.
Cottrell BA; Doolittle RF
Biochim Biophys Acta; 1976 Dec; 453(2):426-38. PubMed ID: 999898
[TBL] [Abstract][Full Text] [Related]
7. Direct analysis of plasma fibrinogen-derived fibrinopeptides by high-performance liquid chromatography: investigation of nine congenital fibrinogen abnormalities.
Southan C; Thompson E; Lane DA
Br J Haematol; 1987 Apr; 65(4):469-73. PubMed ID: 3580304
[TBL] [Abstract][Full Text] [Related]
8. Fibrinogen Seattle II: congenital dysfibrinogenemia with an Arg (A alpha 16)----his substitution.
Ebert RF; Schreiler WE; Bell WR
Thromb Res; 1986 Jul; 43(1):7-13. PubMed ID: 3726812
[TBL] [Abstract][Full Text] [Related]
9. Fibrinogen Magdeburg I: a novel variant of human fibrinogen with an amino acid exchange in the fibrinopeptide A (Aalpha 9, Leu-->Pro).
Meyer M; Kutscher G; Stürzebecher J; Riesener G; Lutze G
Thromb Res; 2003 Jan; 109(2-3):145-51. PubMed ID: 12706644
[TBL] [Abstract][Full Text] [Related]
10. Quantifying thrombin-catalyzed release of fibrinopeptides from fibrinogen using high-performance liquid chromatography.
Ng AS; Lewis SD; Shafer JA
Methods Enzymol; 1993; 222():341-58. PubMed ID: 8412803
[No Abstract] [Full Text] [Related]
11. Assay of bovine fibrinopeptides by high performance liquid chromatography.
Martinelli RA; Scheraga HA
Anal Biochem; 1979 Jul; 96(1):246-9. PubMed ID: 495988
[No Abstract] [Full Text] [Related]
12. Assay of human fibrinopeptides by high-performance liquid chromatography.
Ebert RF; Bell WR
Anal Biochem; 1985 Jul; 148(1):70-8. PubMed ID: 4037309
[TBL] [Abstract][Full Text] [Related]
13. Purification of human fibrinopeptides by high-performance liquid chromatography.
Koehn JA; Canfield RE
Anal Biochem; 1981 Sep; 116(2):349-56. PubMed ID: 7316166
[No Abstract] [Full Text] [Related]
14. Direct analysis of plasma fibrinogen-derived fibrinopeptides by high-performance liquid chromatography.
Southan C; Thompson E; Lane DA
Thromb Res; 1986 Jul; 43(2):195-204. PubMed ID: 3738859
[TBL] [Abstract][Full Text] [Related]
15. Isolation and characterization of the thrombin-like enzyme from Cryptelytrops purpureomaculatus venom.
Tan NH
Comp Biochem Physiol C Toxicol Pharmacol; 2010 Jan; 151(1):131-6. PubMed ID: 19770070
[TBL] [Abstract][Full Text] [Related]
16. Conformational identity of human fibrinogen and monomeric fibrin.
Wiltzius P; Hofmann V
Thromb Res; 1980 Sep; 19(6):793-8. PubMed ID: 7466747
[No Abstract] [Full Text] [Related]
17. Genetically abnormal fibrinogens--strategies for structure elucidation, including fibrinopeptide analysis.
Henschen A; Kehl M; Southan C
Curr Probl Clin Biochem; 1984; 14():273-320. PubMed ID: 6391842
[No Abstract] [Full Text] [Related]
18. Human tissue-type plasminogen activator releases fibrinopeptides A and B from fibrinogen.
Weitz JI; Cruickshank MK; Thong B; Leslie B; Levine MN; Ginsberg J; Eckhardt T
J Clin Invest; 1988 Nov; 82(5):1700-7. PubMed ID: 3141481
[TBL] [Abstract][Full Text] [Related]
19. Effects of fibrinopeptide cleavage on the plasmic degradation pathways of human cross-linked fibrin.
Olexa SA; Budzynski AZ
Biochemistry; 1980 Feb; 19(4):647-51. PubMed ID: 6444516
[TBL] [Abstract][Full Text] [Related]
20. Clottability and cross-linking reactivity of fibrin(ogen) following differential release of fibrinopeptides A and B.
Furlan M; Seelich T; Beck EA
Thromb Haemost; 1976 Dec; 36(3):582-92. PubMed ID: 14415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
